EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Pediococcus acidilactici (pA1c®) alleviates obesity-related dyslipidemia and inflammation in Wistar rats by activating beta-oxidation and modulating the gut microbiota

Deyan Yavorov-Dayliev, Fermín I Milagro, Miguel López-Yoldi, Iñigo Clemente, José Ignacio Riezu-Boj, Josune Ayo, María Oneca, Paula Aranaz

Food & Function · 2023

DOI: 10.1039/d3fo01651j ↗

Kurz gefasst

Fachartikel in der Zeitschrift Food & Function, 2023. Verfasst von Deyan Yavorov-Dayliev und 7 weiteren Autor:innen. Beteiligte Einrichtung: Genbioma Aplicaciones SL, Polígono Industrial Noain-Esquiroz, Calle S, Nave 4, Esquíroz, Navarra, Spain. Hauptthemen laut MEDLINE: Pediococcus acidilactici, Gastrointestinal Microbiome, Hypercholesterolemia. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

pA1c® prevents obesity-related disturbances including hypercholesterolemia and hypertriglyceridemia by reducing inflammation, activating beta-oxidation and reverting gut microbiota dysbiosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pediococcus acidilacticiGastrointestinal MicrobiomeHypercholesterolemiaRatsMaleAnimalsMiceRats, WistarObesityInflammationDiet, High-FatCholesterolMice, Inbred C57BL

Substanzen

Cholesterol

Autor:innen und Institutionen

  • Genbioma Aplicaciones SL, Polígono Industrial Noain-Esquiroz, Calle S, Nave 4, Esquíroz, Navarra, Spain.
  • Faculty of Pharmacy and Nutrition, Department of Nutrition, Food Sciences and Physiology, University of Navarra, 31008 Pamplona, Spain. fmilagro@unav.es.
  • Center for Nutrition Research, University of Navarra, 31008 Pamplona, Spain.
  • Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBERObn), Madrid, Spain.

Förderung

  • Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición

Zitieren

APA

Yavorov-Dayliev, D., Milagro, F. I., López-Yoldi, M., Clemente, I., Riezu-Boj, J. I., Ayo, J., Oneca, M., & Aranaz, P. (2023). Pediococcus acidilactici (pA1c®) alleviates obesity-related dyslipidemia and inflammation in Wistar rats by activating beta-oxidation and modulating the gut microbiota. Food & Function. https://doi.org/10.1039/d3fo01651j

Vancouver

Yavorov-Dayliev D, Milagro FI, López-Yoldi M, Clemente I, Riezu-Boj JI, Ayo J, et al. Pediococcus acidilactici (pA1c®) alleviates obesity-related dyslipidemia and inflammation in Wistar rats by activating beta-oxidation and modulating the gut microbiota. Food & Function. 2023. doi:10.1039/d3fo01651j

BibTeX
@article{YavorovDayliev2023,
  author = {Yavorov-Dayliev, Deyan and Milagro, Fermín I and López-Yoldi, Miguel and Clemente, Iñigo and Riezu-Boj, José Ignacio and Ayo, Josune and Oneca, María and Aranaz, Paula},
  title = {Pediococcus acidilactici (pA1c®) alleviates obesity-related dyslipidemia and inflammation in Wistar rats by activating beta-oxidation and modulating the gut microbiota},
  journal = {Food & Function},
  year = {2023},
  doi = {10.1039/d3fo01651j}
}
Kostenlos starten →